Know Cancer

or
forgot password
  • cancer clinical trials in madison, WI

  • Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Anal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Saint Nicholas Hospital
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Dean Hematology and Oncology Clinic

    Trial Locations
    Dean Hematology and Oncology Clinic
    UW Health Oncology - 1 South Park
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Cervical Cancer, Endometrial Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Kidney Cancer
    TRIAD Burden of Illness Mucositis Study
    Univeristy Of Wisconsin
    Madison, Wisconsin 53705
    Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    UW Health Oncology - 1 South Park
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours
    University of Wisconsin School of Medicine and Public Health
    Madison, Wisconsin 53792-5666
    Endocrine Tumors
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Dean Hematology and Oncology Clinic
    Saint Nicholas Hospital
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Dean Hematology and Oncology Clinic

    Trial Locations
    Dean Hematology and Oncology Clinic
    UW Health Oncology - 1 South Park
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Study of ATN-224 in Patients With Prostate Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Prostate Cancer
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    University of Wisconsin Hospital & Clinics
    Madison, Wisconsin 53792
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    University of Wisconsin School of Medicine and Public Health
    Madison, Wisconsin 53792-5666
    Mycoses, Candidiasis, Invasive, Candidemia
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Dean Hematology and Oncology Clinic
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Recurrent Endometrial Carcinoma
    Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Dean Medical Center - Madison
    Madison, Wisconsin 53717
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
    University of Wisconsin Cancer Center
    Madison, Wisconsin 53792
    Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Endometrial Cancer
    Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Neuroblastoma
    Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Neuroblastoma
    Adult Double Cord Blood Transplant Study
    University of Wisconsin-Madison
    Madison, Wisconsin 53792
    Cord Blood Stem Cell Transplantation, Hematologic Malignancies
    CHESS: Human and Computer Mentors for Prostate Cancer Patients
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Prostate Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Dean Hematology and Oncology Clinic
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Leukemia
    CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
    University of Wisconsin Hospital
    Madison, Wisconsin 53792
    Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Neuroblastoma
    Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma
    University of Wisconsin Cancer Center
    Madison, Wisconsin 53792
    Mantle Cell Lymphoma
    An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
    Uniersity of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Medullary Thyroid Cancer
    Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
    Kenneth DeSantes., MD
    Madison, Wisconsin 53972
    Leukemia, Solid Tumors
    UW/VA Madison Brain Bank
    University of Wisconsin Madison
    Madison, Wisconsin 53792
    Alzheimer's Disease, Parkinson's Disease, ALS, Multiple Sclerosis, Huntington's Disease
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Saint Nicholas Hospital
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Saint Nicholas Hospital
    Madison, Wisconsin 53715
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Saint Nicholas Hospital
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia